Indian equity market saw a mixed bag of performances on Monday. Among the top performers, CreditAccess Grameen Limited and BSE Limited emerged as the notable gainers, while SJVN Limited and Jubilant Pharmova Limited were among the top losers.
Microfinance service provider CreditAccess Grameen witnessed an impressive gain of 8.45%, reaching ₹1507.40 from its last close at ₹1389.85. The company offers microcredit loans for income generation, home improvement, emergency, and family welfare, amongst others.
| Stock | Current Price (₹) | Last Close (₹) | % Change |
|---|---|---|---|
| CreditAccess Grameen Limited | ₹1507.4 | ₹1389.85 | 8.46% |
| BSE Limited | ₹1707.15 | ₹1587.8 | 7.52% |
| Ipca Laboratories Limited | ₹998.8 | ₹935.9 | 6.72% |
| Rainbow Children’s Medicare Limited | ₹1111.35 | ₹1076.55 | 3.23% |
| MedPlus Health Services Limited | ₹801.25 | ₹784.9 | 2.08% |
| Stock | Current Price | Last Close | % Change |
|---|---|---|---|
| SJVN Limited | ₹66.35 | ₹75.35 | -11.94% |
| Jubilant Pharmova Limited | ₹358.5 | ₹400.1 | -10.4% |
| BEML Limited | ₹2058.95 | ₹2291.0 | -10.13% |
| Rashtriya Chemicals and Fertilizers Limited | ₹123.95 | ₹137.65 | -9.95% |
| Finolex Industries Limited | ₹202.65 | ₹224.85 | -9.87% |
Following close on the heels was BSE Limited, which recorded a 7.51% surge, with its stocks trading at ₹1707.15, up from the previous close of ₹1587.80. The surge in the stock came as it made changes to its forcing structure.
See Also: Anushka Sharma And Virat Kohli Launch Event Promotion Venture Nisarga
On the flip side, SJVN Limited, involved in the generation and sale of electricity in India, Nepal, and Bhutan, dropped by a whopping 11.94%, with its current price at ₹66.35, down from ₹75.35.
Pharma major Jubilant Pharmova Limited also had a tough day at the market, with a decline of 10.39%, trading at ₹358.50, down from the last close of ₹400.10. The company operates as an integrated pharmaceutical and life sciences company in India and internationally.
Read Next: Dall E 3 Now Available To Everyone For Free: Here’s How To Access It
Engineered by Benzinga Neuro, Edited by Utkarsh Roshan
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.
Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.